Co-diagnostics, inc. and partner crl to discuss saliva testing and future applications of pcr in 360dx webinar

Salt lake city, april 29, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be accompanying dr. heather fehling, chief scientific officer at clinical reference lab ("crl") in a webinar titled "a new generation of pcr: at-home testing and preparing for emerging strains of covid-19" on thursday, april 29 at 2:00 pm edt. the 360dx webinar is expected to provide insights regarding future applications of pcr testing for covid-19, how crl is able to provide non-invasive and highly accurate saliva pcr tests for at-home collection, and how new pcr science and technology is enabling and expanding the applications and accessibility of pcr tests.
CODX Ratings Summary
CODX Quant Ranking